UBX (Unity Biotechnology, Inc) Bozor qiymatining balans qiymatiga nisbati

Unity Biotechnology, Inc (UBX) kompaniyasining rasmiy ramzlari

Kapitalning suyulishi xavflari va klinik ma'lumotlarning tebranishlari Unity Biotechnology (UBX) uchun noaniqlikni yuzaga keltirmoqda. Geopolitik keskinliklar xalqaro tadqiqotlar va reagentlar yetkazib berishni yanada qiyinlashtirmoqda. Shunga qaramay, Unity Biotechnology (UBX) to'qimalar qarishining tub sabablarini bartaraf etish orqali senolitika sohasida yetakchilik qilmoqda. Buk value ko'rsatkichi ushbu salohiyatni tasdiqlaydi, bunda -20.38 ushbu metrikaning joriy qiymatini belgilab, emitentning aktivlar qiymati bo'yicha bozor konsensusini aks ettiradi.

unitybiotechnology.com (UBX) - Bozor kapitallashuvining balans qiymatiga nisbati 04.07.2022dan 19.07.2025gacha

UBX (Unity Biotechnology Inc.): tahliliy kesimlar va indikatorlar boʻyicha maʼlumotlar

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya narxi Unity Biotechnology|UBX - Investitsiya uylarining umumiy prognozi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor qiymati Unity Bio|UBX - Biznes qiymati
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya hisobiga balans qiymati Unity Biotechnology|UBX - Balans kapitallashuvi|Kapitallashuvning sof aktivlarga nisbati unitybiotechnology.com|UBX - Kompaniyaning umumiy aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Qarzning xususiy kapitalga nisbati Unity Biotechnology|UBX - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Qisqa muddatli qarzning kapitalga nisbati Unity Bio|UBX - Kompaniyaning umumiy qarz majburiyatlari|Qarzning balans qiymatiga nisbati Unity Bio
Kompaniyaning asosiy tahlili:UBX - Unity Biotechnology
Unity Biotechnology Inc. asosiy tovari

Unity Biotechnology ulkan bozor salohiyatiga ega bo'lgan yoshga bog'liq patologiyalarni davolash uchun senolitiklar ishlab chiqishga e'tibor qaratadi. Ushbu ko'rsatkich emitentning joriy bozor qiymatini uning sof aktivlari miqdori bilan solishtiradi. Bozor qiymatining buxgalteriya qiymatiga nisbati (market-to-book ratio) dagi o'zgarishlarni tahlil qilish orqali investor kelajakdagi ishlanmalar uchun to'langan premiumning miqdorini aniqlashi mumkin. Kapitaldan yuqori premium regenerativ tibbiyotga bo'lgan bozor kutganlarini aks ettiradi, holbuki ushbu ko'rsatkichlar orasidagi sezilarli farq narxlar korreksiyasi xavfini oshiradi.

Asosiy raqobatchilar

Bozor kapitallashuvining balans qiymatiga nisbati Tempus Labs|QGEN (qiagen.com) - Kapitallashuvning balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Ionis (IONS)|Kapitallashuvning balans qiymatiga nisbati Repligen Corp|Bozor kapitallashuvining balans qiymatiga nisbati RNA|Bozor kapitallashuvining balans qiymatiga nisbati CRISPR CRSP|Kapitallashuvning sof aktivlarga nisbati WGS (GeneDx Holdings Corp.)|ultragenyx.com - Bozor kapitallashuvining balans qiymatiga nisbati|Beam Therapeutics (BEAM) - Bozor qiymatining balans qiymatiga nisbati|SRPT - Kapitallashuvning balans qiymatiga nisbati|Twist Bio - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi 10x|Intellia Therapeutics (NTLA) - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga multiplikatori stoketherapeutics.com (STOK)|BioLife Solutions - Kapitallashuvning sof aktivlarga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Wave Life Sciences Ltd WVE|Kapitallashuvning sof aktivlarga nisbati Maze Tx|Balans qiymatiga nisbatan bozor qiymati Sionna Corp SION|PRME - Bozor kapitallashuvining balans qiymatiga nisbati|TSHA - Bozor qiymatining balans qiymatiga nisbati|uniQure - Bozor kapitallashuvining balans qiymatiga nisbati|MGTX (MeiraGTx Holdings) - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati RGNX (Regenxbio)|Bozor qiymatining balans qiymatiga koeffitsiyenti Solid Corp (SLDB)|Kapitallashuvning sof aktivlarga nisbati Ocugen, Inc.|Bozor kapitallashuvining balans qiymatiga multiplikatori pacb.com (PACB)|BNTC: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Design Therapeutics Inc DSGN|RCKT: Bozor kapitallashuvining balans qiymatiga nisbati|FDMT - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati lexeotx.com LXEO|KRRO (Korro Bio) - Balans qiymatiga nisbatan bozor qiymati|Bozor qiymatining balans qiymatiga nisbati Editas Medicine (EDIT)|Kapitallashuvning balans qiymatiga nisbati SLN|ProQR Therapeutics N.V. - Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti CDXS (codexis.com)|Bozor qiymatining balans qiymatiga nisbati Sangamo Therapeutics SGMO|Nautilus Biotechnology, Inc. - Bozor qiymatining balans qiymatiga nisbati|MGX (Metagenomi) - Bozor qiymatining balans qiymatiga nisbati|DTIL - Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor kapitallashuvining balans qiymatiga nisbati GBIO (generationbio.com)|Bozor qiymatining xususiy kapitalga nisbati Boundless Bio Inc|Kapitallashuvning sof aktivlarga nisbati XCUR (Exicure Inc.)|Bozor qiymatining balans qiymatiga koeffitsiyenti Celsion Corporation (IMNN)|Kapitallashuvning sof aktivlarga nisbati PHIO|Bozor kapitallashuvining balans qiymatiga nisbati mustangbio.com (MBIO)|Bozor kapitallashuvining balans qiymatiga nisbati TransCode Therapeutics, Inc. RNAZ|BNGO - Bozor qiymatining balans qiymatiga nisbati|Applied DNA Sciences (APDN) - Kapitallashuvning sof aktivlarga nisbati|BLUE - Kapitallashuvning balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati immunoprecise.com|OMGA (Omega Therapeutics Inc) - Kapitallashuvning balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Singular Genomics Systems Inc (OMIC)|Kapitallashuvning balans qiymatiga nisbati Regulus|Bozor kapitallashuvining balans qiymatiga nisbati SYRS|Bozor kapitallashuvining balans qiymatiga nisbati telesisbio.com TBIO|Kapitallashuvning sof aktivlarga nisbati TCON (TRACON Pharmaceuticals, Inc.)